BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37077092)

  • 21. Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases.
    Chagas AL; Kikuchi L; Herman P; Alencar RS; Tani CM; Diniz MA; Pugliese V; Rocha Mde S; D'Albuquerque LA; Carrilho FJ; Alves VA
    Clinics (Sao Paulo); 2015 Mar; 70(3):207-13. PubMed ID: 26017653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Obstructive jaundice caused by hepatocellular carcinoma].
    Nardello O; Farina GP; Cagetti M
    Ann Ital Chir; 2005; 76(6):535-41. PubMed ID: 16821515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small hepatocellular carcinoma presenting as intrabiliary pedunculated polyp and obstructive jaundice.
    Terada T; Nakanuma Y; Kawai K
    J Clin Gastroenterol; 1989 Oct; 11(5):578-83. PubMed ID: 2551956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrolamellar Carcinoma: What Is New and Why It Matters.
    Graham RP
    Surg Pathol Clin; 2018 Jun; 11(2):377-387. PubMed ID: 29751881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Delayed recurrence of an endobiliary hepatocellular carcinoma without detectable intra-parenchymatous tumor].
    Vibert E; Chatelain D; Barrucand C; Garavito R; Yzet T; Delcenserie R; Mauvais F; Riboulot M; Capron JP; Dupas JL; Regimbeau JM
    Gastroenterol Clin Biol; 2006 May; 30(5):790-3. PubMed ID: 16801906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of bile duct hepatocellular carcinoma thrombus without obvious intrahepatic mass.
    Long XY; Li YX; Wu W; Li L; Cao J
    World J Gastroenterol; 2010 Oct; 16(39):4998-5004. PubMed ID: 20954289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of fibrolamellar hepatocellular carcinoma.
    Kearney D; Donlon JB; Mendelson RM
    Australas Radiol; 1991 Feb; 35(1):88-91. PubMed ID: 1650180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Icterus due to tumor emboli--a rare presentation of hepatoma.
    Sastry RA; Raju GS; Kumar YR
    Indian J Gastroenterol; 1996 Jan; 15(1):24-5. PubMed ID: 8840624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extrahepatic intraductal ectopic hepatocellular carcinoma: bile duct filling defect.
    Schmelzle M; Matthaei H; Lehwald N; Raffel A; Tustas RY; Pomjanski N; Reinecke P; Schmitt M; Schulte Am Esch J; Knoefel WT; Eisenberger CF
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):650-2. PubMed ID: 20007086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrolamellar hepatocellular carcinoma: report of a case mimicking a liver abscess.
    Debray D; Pariente D; Fabre M; Foucaud P; Valayer J; Bernard O
    J Pediatr Gastroenterol Nutr; 1994 Nov; 19(4):468-72. PubMed ID: 7877006
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrolamellar carcinoma of the liver: CT, ultrasound and angiography. Case report.
    Bedi DG; Kumar R; Morettin LB; Gourley K
    Eur J Radiol; 1988 May; 8(2):109-12. PubMed ID: 2838279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus, Including Cases with Obstructive Jaundice.
    Orimo T; Kamiyama T; Yokoo H; Wakayama K; Shimada S; Tsuruga Y; Kamachi H; Taketomi A
    Ann Surg Oncol; 2016 Aug; 23(8):2627-34. PubMed ID: 27006124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatoma and obstructive jaundice.
    Cleland PG; Adjukiewicz A
    Postgrad Med J; 1980 May; 56(655):371-2. PubMed ID: 6255454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrolamellar hepatocellular carcinoma coexistent with a hepatocellular carcinoma of common type: report of a case.
    Okada K; Kim YI; Nakashima K; Tada I; Yoshida T; Kobayashi M; Yokoyama S
    Surg Today; 1993; 23(7):626-31. PubMed ID: 7690275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrolamellar hepatocarcinoma: case report and review of the literature.
    Bârsu M
    Rom J Morphol Embryol; 1991; 37(3-4):161-6. PubMed ID: 1667604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.
    Qin LX; Tang ZY
    World J Gastroenterol; 2003 Mar; 9(3):385-91. PubMed ID: 12632482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrolamellar hepatocellular carcinoma occurring 5 years after hepatocellular adenoma in a 14-year-old girl: a case report with comparative genomic hybridization analysis.
    Terracciano LM; Tornillo L; Avoledo P; Von Schweinitz D; Kühne T; Bruder E
    Arch Pathol Lab Med; 2004 Feb; 128(2):222-6. PubMed ID: 14736278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.
    McLarney JK; Rucker PT; Bender GN; Goodman ZD; Kashitani N; Ros PR
    Radiographics; 1999; 19(2):453-71. PubMed ID: 10194790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma with fibrolamellar pattern in a patient with autoimmune cholangitis.
    Singson RC; Fraiman M; Geller SA
    Mt Sinai J Med; 1999 Mar; 66(2):109-12. PubMed ID: 10100415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma.
    Sugiyama G; Okabe Y; Ishida Y; Saitou F; Kawahara R; Ishikawa H; Horiuchi H; Kinoshita H; Tsuruta O; Sata M
    World J Gastroenterol; 2014 Jun; 20(22):6968-73. PubMed ID: 24944490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.